← AI Companies
Consumer telehealth company offering personalized health, wellness and prescription products via an online platform.
- Share Price
- 19.13USD
- Market Cap
- 4.46BUSD
- Revenue
- 2.87BUSD
- Net Income
- -190.84MUSD
Financial data: Yahoo Finance, as of 11-Nov-2026
Price & Size
| Price |
19.13 USD |
| Market Cap |
4.46B USD |
| Shares Outstanding |
224.94M |
| Shares Float |
214.75M |
| 52w Low |
13.74 USD |
| 52w High |
41.28 USD |
| Avg Volume |
11.37M |
Valuation
| P/E (forward) |
35.2x |
| P/B |
12.62x |
| Enterprise Value |
5.33B USD |
| Book Value / Share |
1.52 USD |
| PEG Ratio |
2.09x |
| P/S |
1.56x |
| EV / Revenue |
1.86x |
| EV / EBITDA |
-48.83x |
Income
| Revenue |
2.87B USD |
| Revenue / Share |
12.46 USD |
| EBITDA |
-109.20M USD |
| Net Income |
-190.84M USD |
| EPS (trailing) |
-0.64 USD |
| EPS (forward) |
0.54 USD |
Margins & Profitability
| Gross Margin |
63.8% |
| Operating Margin |
-7.4% |
| Profit Margin |
-6.7% |
| EBITDA Margin |
-3.8% |
| Return on Equity |
-40.8% |
| Return on Assets |
-4.7% |
Cash & Debt
| Total Cash |
712.22M USD |
| Total Debt |
1.56B USD |
| Free Cash Flow |
525.18M USD |
| Operating Cash Flow |
180.12M USD |
| Debt / Equity |
4.39x |
| Current Ratio |
0.92x |
| Quick Ratio |
0.79x |
Dividend
| Yield |
0.0% |
| Payout Ratio |
0.0% |
Analyst Consensus
| Target (Mean) |
30.69 USD |
| Target (Median) |
31.00 USD |
| Target (High) |
42.00 USD |
| Target (Low) |
23.00 USD |
| Analysts' Rating |
Hold |
| # Analysts |
13 |
Identifiers
| ISIN | US4330001060 |
| CUSIP | 433000106 |
| FIGI | BBG00Q53VZ35 |
| SEDOL | BJRD2V9 |
Sentiment 62.0%
as of 11-Nov-2026
Sentiment is an AI (Grok) reading of market mood over the past 30 days: 0% very negative, 50% neutral, 100% very positive.
Positive drivers
HIMS reported strong subscriber growth and revenue expansion in Q3 2026 driven by increased demand for personalized telehealth services. Positive analyst coverage highlighted successful AI integration in diagnostic tools boosting operational efficiency. Strategic partnerships with major insurers expanded market reach during the period.
Neutral / mixed
Broader market volatility in healthcare stocks created mixed trading patterns for HIMS without clear directional momentum. Regulatory updates on telehealth remained stable but pending legislation introduced some uncertainty. Seasonal factors around year-end planning tempered enthusiasm despite solid fundamentals.
Negative drivers
Increased competition from larger players like Teladoc pressured margins and market share in key segments. Rising marketing costs and slower-than-expected international expansion weighed on investor sentiment. Macroeconomic concerns over consumer spending on elective health services added downward pressure.
Bottom line
Overall sentiment for HIMS remains moderately positive amid growth momentum tempered by competitive and macro headwinds. The stock is viewed as a stable performer in the telehealth space with cautious optimism for continued expansion.
NYSE
USD